Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
Imagine using stem cells to rebuild the heart following severe heart failure or coronary heart disease. James T. Willerson, MD, President and Medical Director of the Texas Heart Institute at St. Luke’s…
James T. Willerson, MD, President and Medical Director of the Texas Heart Institute at St. Luke’s Episcopal Hospital, addresses a topic of great concern in cardiology today: leakage following aortic…
Each year in the United States thousands of women undergo a hysterectomy for non-cancer-related gynecological disorders. Many of these procedures are performed using minimally invasive techniques including laparoscopy…
NEW YORK (Reuters Health) – Reducing exposure to alkylating agents in patients with Hodgkin lymphoma is key to reducing the risk of developing therapy-related acute myeloid leukemia or…
James T. Willerson, MD, President and Medical Director of the Texas Heart Institute at St. Luke’s Episcopal Hospital, discusses groundbreaking new therapies to cure cardiovascular disease using stem cell technology.…
John J. Ross, MD, instructor at Harvard Medical School, author of Shakespeare’s Tremor and Orwell’s Cough: Medical Lives of Famous Writers, discusses the medical history of Herman Melville and…
This month in Discussion in Diabetes, Steven Edelman, MD, discusses strategies to help prevent diabetes in your patients. He looks at key risk factors to monitor as well…
It is generally recommended that women who are planning to become pregnant take a daily supplement of folic acid. Taking this supplement has been associated with reduced risk…
Michael Chez, MD, Director of Pediatric Neurology at Sutter Health, examines the vast potential for the use of cord blood stem cell therapy in the treatment of autistic features of…
NEW YORK (Reuters Health) – Agents that target the mTOR axis, which have become particularly important in the treatment of advanced renal cell carcinoma (RCC), have significant adverse…
